By Sriparna Roy and Bhanvi Satija (Reuters) -Shares of global vaccine makers were muted on Tuesday as investors and analysts ...

Novavax, Inc. faces profitability challenges despite a promising tech platform, with uncertain revenue streams. Click for my ...

By Sriparna Roy and Bhanvi Satija (Reuters) -Shares of global vaccine makers were mixed on Tuesday, as investors assessed U.S ...

The main reason for the downturn in Moderna’s stock is a significant drop in the demand for its COVID-19 vaccine.

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured ...

Just two days after retiring the entirety of the US Centers for Disease Control and Prevention’s vaccine advisory panel, US ...

BioNTech is buying fellow German mRNA vaccine developer CureVac in an all-stock transaction that values the acquired biotech ...

Health and Human Services Secretary Robert F. Kennedy Jr.’s moves to upend decades of vaccine policy could hit patients hardest in their wallets, as shifting guidance over shots could make ...

Three of the health secretary’s picks to replace fired members of an influential panel that sets U.S. vaccine policies have ...